187 related articles for article (PubMed ID: 33973539)
21. Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women.
Ebrahimzadeh T; Kuprasertkul A; Neugent ML; Lutz KC; Fuentes JL; Gadhvi J; Khan F; Zhang C; Sharon BM; Orth K; Li Q; Zimmern PE; De Nisco NJ
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 33958485
[TBL] [Abstract][Full Text] [Related]
22. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials.
Beerepoot MA; Geerlings SE; van Haarst EP; van Charante NM; ter Riet G
J Urol; 2013 Dec; 190(6):1981-9. PubMed ID: 23867306
[TBL] [Abstract][Full Text] [Related]
23. Risk factors, demographic profiles, and management of uncomplicated recurrent urinary tract infections: a single institution study.
Ingram A; Posid T; Pandit A; Rose J; Amin S; Bellows F
Menopause; 2021 May; 28(8):943-948. PubMed ID: 33950033
[TBL] [Abstract][Full Text] [Related]
24. Should hormone replacement therapy (any route of administration) be considered in all postmenopausal women with lower urinary tract symptoms? Report from the ICI-RS 2023.
Taithongchai A; Mohamed-Ahmed R; Sinha S; Gibson W; Giarenis I; Robinson D; Abrams P
Neurourol Urodyn; 2024 Aug; 43(6):1321-1327. PubMed ID: 38289324
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
[TBL] [Abstract][Full Text] [Related]
26. Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients.
Bradley MS; Cabrera C; Clark SG; Sassani J; Venuti K; Ackenbom MF
Neurourol Urodyn; 2020 Nov; 39(8):2186-2191. PubMed ID: 32803912
[TBL] [Abstract][Full Text] [Related]
27. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
28. Local oestrogen for vaginal atrophy in postmenopausal women.
Lethaby A; Ayeleke RO; Roberts H
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
[TBL] [Abstract][Full Text] [Related]
29. Direct Detection of Tissue-Resident Bacteria and Chronic Inflammation in the Bladder Wall of Postmenopausal Women with Recurrent Urinary Tract Infection.
De Nisco NJ; Neugent M; Mull J; Chen L; Kuprasertkul A; de Souza Santos M; Palmer KL; Zimmern P; Orth K
J Mol Biol; 2019 Oct; 431(21):4368-4379. PubMed ID: 31002774
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee.
Cardozo L; Lose G; McClish D; Versi E; de Koning Gans H
Int Urogynecol J Pelvic Floor Dysfunct; 2001; 12(1):15-20. PubMed ID: 11294525
[TBL] [Abstract][Full Text] [Related]
31. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
Rozenberg S; Pastijn A; Gevers R; Murillo D
Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
[TBL] [Abstract][Full Text] [Related]
32. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
33. Baseline Characteristics, Evaluation, and Management of Women With Complaints of Recurrent Urinary Tract Infections.
Dieter AA; Mueller MG; Andy UU; Kirby AC; Dwarica DS; Amundsen CL; Gregory WT; Desai S; Clayton L; Squires NA; Allen A; Casper KP; Murphy MJ; Shepherd JP;
Female Pelvic Med Reconstr Surg; 2021 May; 27(5):275-280. PubMed ID: 33909600
[TBL] [Abstract][Full Text] [Related]
34. Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials.
Ahmed H; Davies F; Francis N; Farewell D; Butler C; Paranjothy S
BMJ Open; 2017 May; 7(5):e015233. PubMed ID: 28554926
[TBL] [Abstract][Full Text] [Related]
35. [Primary and secondary prevention of urinary tract infections].
Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Naber KG; Piechota HJ
Urologe A; 2011 Oct; 50(10):1248, 1250-2, 1254-6. PubMed ID: 21927878
[TBL] [Abstract][Full Text] [Related]
36. Long-term antibiotics for preventing recurrent urinary tract infection in children.
Williams G; Craig JC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001534. PubMed ID: 30932167
[TBL] [Abstract][Full Text] [Related]
37. Menopause hormone therapy and urinary symptoms: a systematic review.
Christmas MM; Iyer S; Daisy C; Maristany S; Letko J; Hickey M
Menopause; 2023 Jun; 30(6):672-685. PubMed ID: 37192832
[TBL] [Abstract][Full Text] [Related]
38. Are vaginal estrogens effective for preventing urinary tract infection in postmenopausal women?
Canales JP; Castro V; Rada G
Medwave; 2017 Nov; 17(9):e7093. PubMed ID: 29172018
[TBL] [Abstract][Full Text] [Related]
39. Could sublingual vaccination be a viable option for the prevention of recurrent urinary tract infection in Canada? A systematic review of the current literature and plans for the future.
Nickel JC; Saz-Leal P; Doiron RC
Can Urol Assoc J; 2020 Aug; 14(8):281-287. PubMed ID: 33626320
[TBL] [Abstract][Full Text] [Related]
40. Effects of local estrogen therapy on recurrent urinary tract infections in young females under oral contraceptives.
Pinggera GM; Feuchtner G; Frauscher F; Rehder P; Strasser H; Bartsch G; Herwig R
Eur Urol; 2005 Feb; 47(2):243-9. PubMed ID: 15661421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
